GLP-1 receptor agonists for obesity treatment

Clinical MedicineUpdated Aug 20, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

16 papers

Showing 1-12 of total 16 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2025OpenAlexDirectly related117 citations

Sean Wharton; Louis J. Aronne; Adam Stefański; Nasreen Alfaris; Andreea Ciudin; Koutaro Yokote; Bruno Halpern; Alpana P. Shukla; Chunmei Zhou; Lisa Macpherson; Sheryl Allen; Nadia N. Ahmad; Suzanne Klise

Sep 16, 2025New England Journal of Medicine

2025OpenAlexDirectly related63 citations

The Effect of Semaglutide and GLP-1 RAs on Risk of Nonarteritic Anterior Ischemic Optic Neuropathy

Nadia J Abbass; Raya Nahlawi; Jacqueline K. Shaia; Kevin Allan; David C. Kaelber; Katherine E. Talcott; Rishi P. Singh

Feb 25, 2025American Journal of Ophthalmology

2023OpenAlexDirectly related117 citations

The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)

Roger S. McIntyre; Rodrigo B. Mansur; Joshua D. Rosenblat; Angela T.H. Kwan

Dec 13, 2023Expert Opinion on Drug Safety

2023OpenAlexSupporting evidence2,843 citations

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

A. Michael Lincoff; Kirstine Brown‐Frandsen; Helen M. Colhoun; John Deanfield; Scott S. Emerson; Sille Esbjerg; Søren Hardt‐Lindberg; G. Kees Hovingh; Steven E. Kahn; Robert F. Kushner; Ildiko Lingvay; Tuğçe Kalaycı Oral; Marie Mide Michelsen; Jorge Plutzky; Christoffer W. Tornøe; Donna H. Ryan

Nov 11, 2023New England Journal of Medicine

2023OpenAlexDirectly related237 citations

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach

Jingyue Wang; Quanwei Wang; Xinyu Yang; Wei Yang; Dong-Rui Li; Jingyu Jin; Hui-Cong Zhang; Xianfeng Zhang

Feb 1, 2023Frontiers in Endocrinology

2021OpenAlexDirectly related435 citations

GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects

Xin Zhao; Minghe Wang; Zhitong Wen; Zhihong Lu; Lijuan Cui; Chao Fu; Huan Xue; Yunfeng Liu; Yi Zhang

Aug 23, 2021Frontiers in Endocrinology

2021OpenAlexDirectly related1,961 citations

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Juan P. Frías; Melanie J. Davies; Julio Rosenstock; Federico C. Pérez Manghi; Laura Fernández Landó; Brandon K. Bergman; Bing Liu; Xuewei Cui; Katelyn Brown

Jun 25, 2021New England Journal of Medicine

2021OpenAlexSupporting evidence4,781 citations

Once-Weekly Semaglutide in Adults with Overweight or Obesity

John Wilding; Rachel L. Batterham; Salvatore Calanna; Melanie J. Davies; Luc F. Van Gaal; Ildiko Lingvay; Barbara McGowan; Julio Rosenstock; Marie Thi Dao Tran; Thomas A. Wadden; Sean Wharton; Koutaro Yokote; Niels Zeuthen; Robert F. Kushner

Feb 10, 2021New England Journal of Medicine

2020OpenAlexDirectly related1,951 citations

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

Philip N. Newsome; Kristine Buchholtz; Kenneth Cusi; Martin Linder; Takeshi Okanoue; Vlad Ratziu; Arun J. Sanyal; Anne‐Sophie Sejling; Stephen A. Harrison

Nov 13, 2020New England Journal of Medicine

2020OpenAlexDirectly related1,561 citations

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

Michael A. Nauck; Daniel R. Quast; Jakob Wefers; Juris J. Meier

Oct 14, 2020Molecular Metabolism

2020OpenAlexSupporting evidence511 citations

Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist

Francis S. Willard; Jonathan D. Douros; M Gabe; Aaron D. Showalter; David B. Wainscott; Todd M. Suter; Megan E. Capozzi; Wijnand J. C. van der Velden; Cynthia Stutsman; Guemalli R. Cardona; Shweta Urva; Paul J. Emmerson; Jens J. Holst; David A. D’Alessio; Matthew P. Coghlan; Mette M. Rosenkilde; Jonathan E. Campbell; Kyle W. Sloop

Jul 30, 2020JCI Insight

2019OpenAlexDirectly related930 citations

The Discovery and Development of Liraglutide and Semaglutide

Lotte Bjerre Knudsen; Jesper Lau

Apr 12, 2019Frontiers in Endocrinology